| Literature DB >> 30363302 |
Maria Longo, Juliano Adams Perez, Francine Oliveira1, Apio Antunes2, Leonardo Vedolin3, Juliana Avila Duarte4.
Abstract
A 17-year-old male patient with history of intraventricular haemorrhage in 2007 underwent a brain MRI scan in 2013 owing to headache. Brain MRI scan showed an expansive lesion adjacent to the left lateral ventricle infiltrating the anterior portion of the corpus callosum. After surgery, pathology confirmed a pilomyxoid astrocytoma (PMA), an aggressive subtype of astrocytoma that occurs predominantly in the hypothalamic-chiasmatic region. On imaging, PMA presents as a tumour isointense on T 1, hyperintense on T 2 that enhanced heterogeneously with contrast. The T 2 signal is higher than pilocytic astrocytoma, which indicates the presence of myxoid matrix. These findings on MRI scan have a direct correlation with a specific pathological finding-monomorphic proliferation of piloid cells in a mucopolysaccharide-rich matrix. These characteristics associated with the absence of Rosenthal fibres or eosinophilic granules indicated the diagnosis of PMA. To our knowledge, this is the first case report of PMA affecting the corpus callosum in an adolescent.Entities:
Year: 2017 PMID: 30363302 PMCID: PMC6159255 DOI: 10.1259/bjrcr.20150020
Source DB: PubMed Journal: BJR Case Rep ISSN: 2055-7159
Figure 1.Axial brain MRI scan shows an intraventricular expansive lesion with hypointense signal on T1 (a) and hyperintense signal on FLAIR (b). Axial gradient echo shows the haemorrhagic component (c). Sagittal contrast-enhanced T1 weighted shows the lesion enhanced heterogeneously by the gadolinium (d). It occupies predominantly the anterior horn of the left lateral ventricle—coronal contrast-enhanced T1 (e) and infiltrates the anterior portion of the corpus callosum—sagittal T1 (f). FLAIR, fluid-attenuated inversion-recovery.
Figure 2.H&E (200×): the image shows a moderate cellularity neoplasm, consisting of rounded and oval cells without significant atypia, embedded in a myxoid stroma (a). GFAP (200×): strong positivity to GFAP, confirming the glial phenotype and showing cells with elongated processes (b). Ki-67: several cells stained with ki-67, demonstrating moderate proliferative index, beyond that expected for pilocytic astrocytoma and compatible with the diagnosis ofpilomyxoid astrocytoma (c). GFAP, glial fibrillary acidic protein; H&E, hematoxylin & eosin.
Differential diagnostic between PMA and PA[3,5,13–15]
| PMA | PA | |
|---|---|---|
| Clinical features | ||
| Age | Mean 18 months | Mean 58 months |
| Symptoms | Signs of increased intracranial pressure | Signs of increased intracranial pressure and visual loss (pathway lesions) |
| Prognosis | Higher recurrence rate than PA | Survival rates at 20 years of 70% |
| Radiological feature | ||
| Haemorrhage | Common (25%) | Rare (less than 8%) |
| T1WI | Large mass uniformly (60%) hypointense | Solid-cystic mass |
| T2WI | Hyperintense (homogeneous in 70%) | Hyperintense |
| Diffusion | Typically does not restrict | Same diffusivity of grey matter |
| Enhancement | Strong and heterogeneous enhancement | Strong and heterogeneous enhancement |
| Leptomeningeal metastases | Common | Rare |
| Location | Suprasellar (60%) | Cerebellum (60%) > Optic nerve/chiasm (30%) |
| Pathological features | ||
| WHO grade | II | I |
| Proliferative index | Moderate | Lower to moderate |
| Myxoid stroma | Predominant | Poor |
| Calcification | Rare | Common |
| Rosenthal fibers | Absent | Present |
| Eosinophilic granular bodies | Absent | Present |
| Tumour cells | Monomorphic | Bipolar |
| Angiocentric patter | Frequent | Rare |
PA, pilocytic astrocytoma; PMA, pilomyxoid astrocytoma; T1WI, T1 weighted image; T2WI, T2 weighted image; WHO, World Health Organization.